Immutep Stock (NASDAQ: IMMP) stock price, news, charts, stock research, profile.
You can purchase shares of Immutep (NASDAQ:IMMP) through any online brokerage.
Other companies in Immutep’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), Inozyme Pharma (NASDAQ:INZY), Voyager Therapeutics (NASDAQ:VYGR) and Korro Bio (NASDAQ:KRRO).
Immutep has a consensus price target of $8.67.
The stock price for Immutep (NASDAQ: IMMP) is $2.2923 last updated September 25, 2024 at 9:41 AM EDT.
There are no upcoming dividends for Immutep.
Immutep’s FY earnings are confirmed for Tuesday, October 8, 2024.
There is no upcoming split for Immutep.
Immutep is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.